newsfilter
← Latest News
GlobeNewswire·

BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review

Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial BiomX continues to see potential in BX011, its phage